Julia M. Hofstra
Ede, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
The Effect of Niacinamide Supplementation on Phosphate Concentrations in Dutch Dialysis Patients: A Randomized Crossover Trial.
Journal: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation
Published: August 06, 2023
Antibody-Guided Therapy in Phospholipase A2 Receptor-Associated Membranous Nephropathy.
Journal: Kidney international reports
Published: July 03, 2022
Investigating the use of support in secondary school: the role of self-reliance and stigma towards help-seeking.
Journal: Journal of mental health (Abingdon, England)
Published: May 03, 2022
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis.
Journal: Nature communications
Published: August 28, 2019
Interleukin-6 is essential for glomerular immunoglobulin A deposition and the development of renal pathology in Cd37-deficient mice.
Journal: Kidney international
Published: September 06, 2017
Neutrophil Extracellular Traps Drive Endothelial-to-Mesenchymal Transition.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: January 03, 2017
Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous Nephropathy.
Journal: Journal of the American Society of Nephrology : JASN
Published: September 22, 2016
Pharmacological treatment of primary membranous nephropathy in 2016.
Journal: Expert review of clinical pharmacology
Published: August 19, 2016
Should aspirin be used for primary prevention of thrombotic events in patients with membranous nephropathy?
Journal: Kidney international
Published: January 04, 2016
Serum anti-PLA2R antibodies can be initially absent in idiopathic membranous nephropathy: seroconversion after prolonged follow-up.
Journal: Kidney international
Published: May 30, 2015
A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN study.
Journal: Clinical kidney journal
Published: May 08, 2015
Last Updated: 09/26/2026